AIM ImmunoTech News - June 2026
🔴 AIM ImmunoTech Inc is trading 87% down today after highly dilutive NYSE-compliance financing
AIM ImmunoTech Inc is trading 86.5% down today at $0.37 following a sharp decline triggered by a heavily dilutive equity and warrant financing package. • The...
🔴 AIM ImmunoTech Inc is trading 5.1% down today, extending selloff after dilutive financing for NYSE compliance
AIM ImmunoTech Inc is trading at $0.38 (5.1% down) in pre-market, extending a sharp selloff triggered by a major capital restructuring aimed at maintaining its...
🔴 AIM ImmunoTech Inc is trading 85% down today on heavy dilution from equity issuances used to regain NYSE compliance
AIM ImmunoTech Inc is trading 85% down today at $0.41 as investors react to significant shareholder dilution following recent equity and warrant issuances. •...
🔴 AIM ImmunoTech Inc is trading 84.27% down today after regaining NYSE American compliance and disclosing new financing
AIM ImmunoTech Inc is trading at $0.43 (-84.27%) after regaining NYSE American compliance with stockholders’ equity requirements. • The exchange removed the...
AIM ImmunoTech's Fire-Sale Capital Raise Wipes Out 84% of Shareholder Value — Can This Biotech Survive Its Own Desperation?
Shares of AIM ImmunoTech (AIM) cratered 83.7% in a single session, plunging from $2.79 to $0.45, after the company announced a deeply discounted capital raise...
🔴 AIM ImmunoTech Inc is trading 84% down today following heavy dilution from a $2.65M equity offering
AIM ImmunoTech Inc is trading 84% down at $0.45 following an extreme dilution-driven selloff tied to its latest capital raise. • The company announced a $2.65...
🔴 AIM ImmunoTech Inc is trading 85.4% down today after $2.65M at-market financing announcement
AIM ImmunoTech Inc is trading 85.4% down at $0.40 after announcing a $2.65 million at-market financing on June 9, 2026. • The financing was priced at $0.5189...